|
REV3L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.270210E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.649800E-02 |
| Normal-vs-Stage2 |
2.864800E-01 |
| Normal-vs-Stage3 |
6.056000E-01 |
| Normal-vs-Stage4 |
7.809200E-01 |
| Stage1-vs-Stage2 |
9.469200E-01 |
| Stage1-vs-Stage3 |
1.032770E-01 |
| Stage1-vs-Stage4 |
1.294760E-01 |
| Stage2-vs-Stage3 |
4.380400E-01 |
| Stage2-vs-Stage4 |
3.826800E-01 |
| Stage3-vs-Stage4 |
8.305000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.645640E-01 |
| Normal-vs-AfricanAmerican |
3.549000E-01 |
| Normal-vs-Asian |
3.207400E-01 |
| Caucasian-vs-AfricanAmerican |
9.463000E-01 |
| Caucasian-vs-Asian |
6.939800E-01 |
| AfricanAmerican-vs-Asian |
7.303400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.174570E-01 |
| Normal-vs-Female |
2.615600E-01 |
| Male-vs-Female |
6.282200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.686800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.937500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.646800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.483600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.334200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.410400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.219600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.640100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.046800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.072800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.516580E-03 |
| Normal-vs-Grade 2 |
4.835100E-03 |
| Normal-vs-Grade 3 |
6.864200E-01 |
| Normal-vs-Grade 4 |
3.231000E-01 |
| Grade 1-vs-Grade 2 |
1.482810E-01 |
| Grade 1-vs-Grade 3 |
2.758600E-03 |
| Grade 1-vs-Grade 4 |
9.620800E-04 |
| Grade 2-vs-Grade 3 |
1.980410E-03 |
| Grade 2-vs-Grade 4 |
6.226200E-04 |
| Grade 3-vs-Grade 4 |
1.115240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.187600E-04 |
| Normal-vs-ccB subtype |
5.811800E-01 |
| ccA subtype-vs-ccB subtype |
3.08299999973727E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.671620E-01 |
| Normal-vs-N1 |
3.225600E-01 |
| N0-vs-N1 |
4.676000E-02 |
|
|
